Outflow Tract Calcification and the Best Valve in This Context

Moderate or severe left ventricle outflow tract calcification increases the risk of annulus rupture, residual aortic regurgitation and the need for a second valve. This recent study analyzed the performance of different contemporary prosthetic valves in patients with this particular anatomy. 

Calcificación del tracto de salida

Since the early days of transcatheter aortic valve replacement (TAVR) outflow tract calcification has been associated to adverse events. In addition, the evidence available was limited to a modest number of observational studies, incomplete followup and the lack of study of the difference devices. 

Moderate or severe calcification was considered with at least 2 nodules, or one extending over 5 mm, or covering over 10% of the outflow tract perimeter.

Of 1635 patients undergoing TAVR, moderate to severe calcification of the outflow tract was documented in nearly 25% of patients (407 patients, 24.9%).

These patients showed a significantly higher risk of annulus rupture (2.3% vs 0.2%; p<0.001), the need for a second valve (2.9% vs 0.8%; p=0.004) and residual aortic failure (11.1% vs. 6.3%; p=0.002).


Read also: ESC 2020 | Ticagrelor Might Increase Bleeding and Mortality in the Elderly.


The balloon expandable valve showed higher risk of annulus rupture in these patients (4.0% vs. 0.4%; p=0.002) vs all the self-expandable valves.

The need for a second valve and residual regurgitation resulted similar across device range. 

Conclusion

Outflow tract calcification increases the risk of annulus rupture, residual aortic regurgitation and the need for a second valve. Annulus rupture resulted far more frequent with the balloon expandable valve, while the rest of complications resulted similar across devices. 

Título original: Impact of Left Ventricular Outflow Tract Calcification on Procedural Outcomes After Transcatheter Aortic Valve Replacement.

Referencia: Taishi Okuno et al. J Am Coll Cardiol Intv 2020;13:1789–99. https://doi.org/10.1016/j.jcin.2020.04.015.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....